Filter By:

Small molecule inhibitors and culture conditions enhance therapeutic cell and EV potency via activation of beta-catenin and suppression of THY1

Ahmed Gamal-EldinIbrahim Ph.D., MPH, Chang Li BS, Alessandra Ciullo Ph.D. K. Candis Jones-Ungerleider MD, MSE, Kiel Peck BS, Linda Marbán Ph.D, Eduardo Marbán MD, Ph.D

View Article

The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike

Chenxu Guo, Shang-Jui Tsai, Yiwei Ai, Maggie Li, Andrew Pekosz, Andrea Cox, Nadia Atai, Stephen J. Gould

View Article

Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial

Raj R Makkar, Dean J Kereiakes, Frank Aguirre, Glenn Kowalchuk, Tarun Chakravarty, Konstantinos Malliaras, Gary S Francis, Thomas J Povsic, Richard Schatz, Jay H Traverse, Janice M Pogoda, Rachel R Smith, Linda Marbán, Deborah D Ascheim, Mohammad R Ostovaneh, João A C Lima, Anthony DeMaria, Eduardo Marbán, Timothy D Henry

View Article

Allogeneic cardiosphere derived cells (CAP 1002) in critically ill COVID 19 patients: compassionate use case series

Siddharth Singh, Tarun Chakravarty, Peter Chen, Akbarshakh Akhmerov, Jeremy Falk, Oren Friedman, Tanzira Zaman, Joseph E. Ebinger, Mitch Gheorghiu · Linda Marbán, Eduardo Marbán, Raj R. Makkar

View Article

MicroRNA composition delineates cardiosphere-derived cell and mesenchymal stem cell extracellular vesicles

Ann-Sophie Walravens, Sasha Smolgovsky, Liang Li, Lauren Kelly, Travis Antes, Kiel Peck, Tanner Quon, Linda Marbán, Benjamin Berman, Luis R. Borlado, Geoffrey de Couto

View Article

Allogeneic Cardiosphere-derived Cells for the Treatment of Heart Failure with Reduced Ejection Fraction: Results of the Dilated cardiomyopathy iNtervention with Allogeneic Myocardially-regeneratIve Cells (DYNAMIC) trial

Chakravarty T, Henry TD, Kittleson M, Lima J, Siegel RJ, Slipczuk L, Pogoda JM, Smith RR, Malliaras K, Marbán L, Ascheim DD, Marbán E, Makkar RR.

View Article

Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories

Ahmed G. E. Ibrahim, Chang Li, Russel Rogers, Mario Fournier, Liang Li, Sharon D. Vaturi, Travis Antes, Lizbeth Sanchez, Akbarshakh Akhmerov, Jennifer Johnson Moseley, Brooke Tobin, Luis Rodriguez-Borlado, Rachel R. Smith, Linda Marbán & Eduardo Marbán

View Article

Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice

Russell G. Rogers, Mario Fournier, Lizbeth Sanchez, Ahmed G. Ibrahim, Mark A. Aminzadeh, Michael I. Lewis, and Eduardo Marbán  

View Article

Cardiac and Skeletal Muscle Effects in the Randomized HOPE–Duchenne Trial

Michael Taylor, MD,* John Jefferies, MD,* Barry Byrne, MD, Joao Lima, MD, Bharath Ambale-Venkatesh, PhD, Mohammad R. Ostovaneh, MD, Raj Makkar, MD, Bryan Goldstein, MD, Rachel Ruckdeschel Smith, PhD,James Fudge, MD, Konstantinos Malliaras, MD, Brian Fedor, BS, Jeff Rudy, BS, Janice M. Pogoda, PhD, Linda Marban, PhD, Deborah D. Ascheim, MD, Eduardo Marban, MD, PhD, and Ronald G. Victor

View Article

Abstract 20536: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR): the One Year Phase I Results

Raj Makkar, Richard Schatz, Jay Traverse, Andrew Hamer, Katherine Beattie, Rachel R Smith, Francie Kivel, Linda Marbán, Eduardo Marbán, and Timothy D Henry

View Article